Mucocutaneous leishmaniasis (MCL) is endemic in the tropical Amazonian lowlands of Bolivia, an area that regularly receives influxes of migratory populations. In these new agricultural development areas, a campaign to diagnose and treat the disease was carried out between 1989 and 1992, in order to provide direct access to MCL treatment in the endemic areas at a standard equivalent to that offered in the urban centres in Bolivia. The campaign led to the creation of decentralized local centres for diagnosis and treatment of the disease. A campaign to inform the population about leishmaniasis was also undertaken and courses were run to educate medical and paramedical personnel. As a result of the campaign, 3285 cases of leishmaniasis were diagnosed, including 2152 cutaneous and 326 mucosal forms. Also, a total of 1888 cases were treated, 1677 of which cutaneous and 211, mucosal.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2486653PMC

Publication Analysis

Top Keywords

campaign diagnose
8
diagnose treat
8
mucocutaneous leishmaniasis
8
rural campaign
4
treat mucocutaneous
4
leishmaniasis
4
leishmaniasis bolivia
4
bolivia mucocutaneous
4
leishmaniasis mcl
4
mcl endemic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!